PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
1-Year Return
21.39%
This Quarter Return
+6.98%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.87B
AUM Growth
-$212M
(-6.9%)
Cap. Flow
-$348M
Cap. Flow
% of AUM
-12.14%
Top 10 Holdings %
Top 10 Hldgs %
36.49%
Holding
88
New
9
Increased
10
Reduced
24
Closed
13
Top Buys
| 1 |
Pfizer
PFE
|
$79.3M |
| 2 |
iRhythm Technologies
IRTC
|
$61.7M |
| 3 |
Johnson & Johnson
JNJ
|
$55.6M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$41.1M |
| 5 |
Cardinal Health
CAH
|
$32.9M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$62.6M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$50.6M |
| 3 |
HCA Healthcare
HCA
|
$50.1M |
| 4 |
Gilead Sciences
GILD
|
$42.8M |
| 5 |
McKesson
MCK
|
$42.8M |
Sector Composition
| 1 | Healthcare | 96.34% |
| 2 | Financials | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
26
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $46.3M | 1.58% |
315,449
+14,904
| +5% | +$2.19M |
|
27
Syndax Pharmaceuticals
SNDX
$1.46B
| $46M | 1.57% |
2,103,512
+246,774
| +13% | +$5.4M |
|
28
AstraZeneca
AZN
$253B
| $45.8M | 1.56% |
785,748
| – | – |
|
|
29
McKesson
MCK
$85.8B
| $44M | 1.5% |
177,000
-172,181
| -49% | -$42.8M |
|
30
Waters Corp
WAT
$18.2B
| $43.8M | 1.49% |
117,634
| – | – |
|
31
Tenet Healthcare
THC
$17.2B
| $43M | 1.46% |
525,927
-141,146
| -21% | -$11.5M |
|
|
CTLT
32
DELISTED
CATALENT, INC.
CTLT
| $41.8M | 1.42% |
326,700
+148,900
| +84% | +$19.1M |
|
|
SGEN
33
DELISTED
Seagen Inc. Common Stock
SGEN
| $41.5M | 1.41% |
268,527
-96,103
| -26% | -$14.9M |
|
34
Thermo Fisher Scientific
TMO
$186B
| $41.5M | 1.41% |
62,143
-9,299
| -13% | -$6.2M |
|
|
35
BioMarin Pharmaceuticals
BMRN
$11.1B
| $41.1M | 1.4% |
+464,940
| New | +$41.1M |
|
|
NVRO
36
DELISTED
NEVRO CORP.
NVRO
| $39.3M | 1.34% |
485,135
+92,349
| +24% | +$7.49M |
|
37
Neurocrine Biosciences
NBIX
$14.4B
| $33.6M | 1.14% |
394,058
-470,021
| -54% | -$40M |
|
|
JNCE
38
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $33.2M | 1.13% |
3,972,868
+124,046
| +3% | +$1.04M |
|
|
39
Cardinal Health
CAH
$35.5B
| $32.9M | 1.12% |
+639,783
| New | +$32.9M |
|
40
Heron Therapeutics
HRTX
$201M
| $32.1M | 1.09% |
3,512,348
+518,802
| +17% | +$4.74M |
|
41
SOPHiA GENETICS
SOPH
$220M
| $27.5M | 0.94% |
1,952,152
-70,400
| -3% | -$993K |
|
|
KRTX
42
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $23.2M | 0.79% |
177,091
| – | – |
|
43
Molina Healthcare
MOH
$9.37B
| $22.3M | 0.76% |
70,088
| – | – |
|
44
Intellia Therapeutics
NTLA
$1.28B
| $21.1M | 0.72% |
178,222
| – | – |
|
45
Elevance Health
ELV
$70.6B
| $19.8M | 0.67% |
+42,734
| New | +$19.8M |
|
|
CANO
46
DELISTED
Cano Health, Inc.
CANO
| $17.1M | 0.58% |
19,146
-1,797
| -9% | -$1.6M |
|
|
ISEE
47
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $16.8M | 0.57% |
1,005,216
-132,896
| -12% | -$2.22M |
|
48
Novavax
NVAX
$1.27B
| $12.7M | 0.43% |
88,663
-108,545
| -55% | -$15.5M |
|
49
Praxis Precision Medicines
PRAX
$1B
| $12.5M | 0.43% |
42,394
+12,036
| +40% | +$3.56M |
|
50
Butterfly Network
BFLY
$390M
| $12.2M | 0.42% |
1,828,311
| – | – |
|